Back to Agenda
Closing Session: Question and Answer with FDA
Session Chair(s)
Lucy Rose, MBA
President
Lucy Rose and Associates, United States
Use this unique opportunity to bring your pressing questions for the FDA to address in person. This session will attempt to answer any remaining questions from earlier sessions and to allow the audience to ask new questions to our FDA speakers.
Speaker(s)
Panelists
Thomas W. Abrams, MBA, RPh
Former FDA, United States
Retired, Director, Office of Prescription Drug Promotion, OMP, CDER
Sonny Saini, PharmD
Sonny Saini, PharmD
FDA, United States
Regulatory Health Project Manager
Alpita Popat, PharmD, MBA
Alpita Popat, PharmD, MBA
FDA, United States
Health Science Policy Analyst
Deborah Wolf, JD
Deborah Wolf, JD
FDA, United States
Regulatory Counsel, OPEQ , Regulatory Policy, CDRH
CDR Roberta Szydlo, MBA, RPh, RAC
CDR Roberta Szydlo, MBA, RPh, RAC
FDA, United States
Office of Prescription Drug Promotion, CDER
Thomas J. Moskal, DVM
Thomas J. Moskal, DVM
FDA/CVM, United States
Veterinary Medical Officer
Have an account?